Free Trial
CVE:GSD

Devonian Health Group (GSD) Stock Price, News & Analysis

C$0.16
-0.01 (-3.13%)
(As of 09/6/2024 05:28 PM ET)
Today's Range
C$0.16
C$0.16
50-Day Range
C$0.13
C$0.20
52-Week Range
C$0.11
C$0.35
Volume
1,000 shs
Average Volume
22,295 shs
Market Capitalization
C$22.97 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Devonian Health Group

Devonian Health Group Inc. engages in the development of botanical drugs. Its lead product candidate is Thykamine, completed Phase IIa clinical trial product for the treatment of ulcerative colitis and atopic dermatitis. The company also develops Pantoprazole Magnesium for the treatment of gastric; Cleo-35 for the treatment of hormonal acne in women; and value-added products for dermo-cosmetics. In addition, the company acquires drug and health product licenses; and distributes pharmaceutical products. Devonian Health Group Inc. was incorporated in 2015 and is headquartered in Québec, Canada.

GSD Stock Price History

GSD Stock News Headlines

The $15 "Insider Secret" That Could Save Your Retirement
What if I told you there's a $15 stock that a billionaire insider just poured $47 MILLION into? That's right. You can grab shares of this potential retirement-maker for less than you'd pay for lunch.
Devonian Health Group Inc.
The $15 "Insider Secret" That Could Save Your Retirement
What if I told you there's a $15 stock that a billionaire insider just poured $47 MILLION into? That's right. You can grab shares of this potential retirement-maker for less than you'd pay for lunch.
Devonian Health Group Inc (GSD)
See More Headlines
Receive GSD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Devonian Health Group and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
Computer Software
CIK
N/A
Fax
N/A
Employees
6
Year Founded
N/A

Profitability

Net Income
C$-3,170,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$9.75 million
Cash Flow
C$0.03 per share
Book Value
C$0.09 per share

Miscellaneous

Free Float
N/A
Market Cap
C$22.97 million
Optionable
Not Optionable
Beta
1.32
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Luc D. Gregoire CA (Age 64)
    CPA, President, CEO & Director
  • Ms. Colette Laurin C.A.
    CPA, Interim CFO, Corporate Secretary & Corporate Controller
  • Dr. Andre P. Boulet Ph.D. (Age 65)
    Chief Scientific Officer & Director
    Comp: $644.63k

GSD Stock Analysis - Frequently Asked Questions

How have GSD shares performed this year?

Devonian Health Group's stock was trading at C$0.15 at the start of the year. Since then, GSD shares have increased by 6.9% and is now trading at C$0.16.
View the best growth stocks for 2024 here
.

How do I buy shares of Devonian Health Group?

Shares of GSD stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (CVE:GSD) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners